Stock Events

Stock Events

Apellis Pharmaceuticals (1JK.F) Q2 2025 Earnings

7MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.65

-0.53

-0.4

-0.27

Details

Expected EPS

-0.30448339124

Actual EPS

-0.6542858

Surprise EPS

-0.35

Surprise Percent

+114.88%

Description

Apellis Pharmaceuticals (1JK.F) has reported earnings of -0.6542858 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.